A new way to begin the diabetes conversation

Diabetes appointments often begin with a number: A1C, the blood test used to estimate average blood sugar over roughly three months. That measure is important, but Yale researchers argue it can dominate a clinical encounter so completely that other priorities go unexplored.

In two related papers published in JAMA Network Open and the Journal of General Internal Medicine, researchers led by Yale School of Medicine endocrinologist Kasia Lipska tested a structured approach intended to give patients more influence over what is discussed during diabetes care.

The tool is called QBSAFE. It consists of 14 conversation cards covering quality of life, the work of diabetes management, treatment safety and complications. Before an appointment, patients select up to three cards that identify issues they want to address, helping establish the visit’s agenda.

Beyond glucose metrics

A1C helps clinicians decide whether a patient’s diabetes medication should be adjusted. But people living with diabetes also manage injections or other medications, glucose monitoring, food choices, physical activity and repeated medical appointments. The practical and emotional weight of that work may not fit easily into a visit centered on a laboratory result.

“What matters most to someone living with diabetes doesn’t always make it into the clinic visit,” Lipska said in material released by Yale. She noted that when blood sugar becomes the sole focus, there may be little time to discuss other circumstances shaping a person’s health.

The premise behind QBSAFE is straightforward: patients should have a clear, low-barrier way to signal what they need from a conversation. The cards are not intended to replace clinical assessment or glucose management. Instead, they provide a prompt for subjects that may otherwise remain unspoken.

How the card system works

Each QBSAFE card contains a statement about life with diabetes or its treatment. The topics include frustration with the time spent managing diabetes, difficulty following advice about diet and exercise, concerns about treatment safety and complications, and moments of pride in managing the condition.

Patients choose up to three cards before seeing a clinician. That selection creates a focused starting point and lets the patient bring concerns into the appointment without needing to introduce them spontaneously during a time-limited discussion.

The researchers developed the cards using prior research on issues that affect quality of life for people with diabetes, along with feedback from patients. That development process matters because it grounds the prompts in experiences that patients themselves have identified as relevant, rather than relying solely on clinicians to anticipate every concern.

Giving patients a greater voice in their diabetes care
Kasia Lipska, MD, MHS, with a patient. Credit: Yale University

Making room for the burden of care

Diabetes is a chronic condition that can involve daily decisions and recurring tasks. Even an effective treatment plan can be hard to carry out if it creates an unsustainable workload or does not fit a person’s circumstances. A patient may be struggling with the logistics of medication, the demands of monitoring, or the emotional pressure of trying to meet clinical targets.

QBSAFE is designed to make such burdens visible. A patient who selects a card about being overwhelmed, for example, can direct the visit toward practical support, treatment trade-offs or a discussion of what is realistically manageable. Someone who chooses a card about safety or complications can ensure that concern is explicitly addressed.

There is also value in the positive prompts. Acknowledging pride or success in diabetes management can give clinicians a better picture of what strategies are working and may support a more balanced conversation than one framed only around problems or numerical targets.

What patient-centered care can mean in practice

Patient-centered diabetes care does not mean that clinical measures such as A1C no longer matter. It means placing those measures within a fuller understanding of a person’s goals, capabilities and day-to-day experience. Treatment decisions can be more useful when patients have an opportunity to explain the constraints and outcomes they value.

The card approach is notable because it is simple. It does not depend on a new device, an algorithm or an extensive clinical workflow. Its intervention is conversational: it changes who sets the agenda and how a clinician learns what may be affecting a patient’s health.

That simplicity could be especially relevant in routine care, where limited time can make it difficult to cover both biomedical targets and the lived experience of chronic disease. By narrowing the patient’s priorities to a small number of chosen prompts, the cards offer structure without requiring every issue to be solved in a single visit.

An early model for better conversations

The two papers examine a specific tool rather than establishing a universal model for diabetes care. Still, the work points to an important direction for chronic-disease management: care plans may be stronger when they make room for the work patients do outside the clinic.

The researchers’ approach recognizes that people are not simply recipients of treatment recommendations. They are the people who must incorporate medication, monitoring and behavioral changes into their own lives. Giving them a direct role in defining an appointment’s priorities can help reveal problems that a lab value alone cannot show.

For clinicians, the cards may offer a practical way to open conversations that are otherwise difficult to start. For patients, they provide permission and a structure to raise what matters most. The central message is not that diabetes metrics should be ignored, but that successful care depends on understanding the person who lives with them.

This article is based on reporting by Medical Xpress. Read the original article.

Originally published on medicalxpress.com